132 related articles for article (PubMed ID: 6925459)
21. Combined radiotherapy and Corynebacterium parvum treatment of rat tumors with different immunogenicity.
Moroson H; Stowe S; Rotman M; Schechter M
Int J Radiat Oncol Biol Phys; 1978; 4(7-8):649-55. PubMed ID: 711536
[No Abstract] [Full Text] [Related]
22. Inhibitory effect of Propionibacterium acnes on the growth on syngeneic tumor transplants in nude mice.
Katahira SI; Kitamura H; Ito M; Minami K; Shigeta S
Fukushima J Med Sci; 1979; 26(3-4):93-9. PubMed ID: 318050
[No Abstract] [Full Text] [Related]
23. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
Moore K; McBride WH
Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
[TBL] [Abstract][Full Text] [Related]
24. Lysozyme levels and macrophage content of tumor tissue in C3H mice bearing fibrosarcoma transplants treated by radiation and Corynebacterium parvum.
Mendiondo O; Suit H; Fixler H
Int J Radiat Oncol Biol Phys; 1978; 4(9-10):829-34. PubMed ID: 711553
[No Abstract] [Full Text] [Related]
25. The effect of Corynebacterium parvum on T cell dependent tumor regression.
McBride WH; Peters LJ; Mason KA; Barrow G
J Reticuloendothel Soc; 1980 Feb; 27(2):151-8. PubMed ID: 6965725
[No Abstract] [Full Text] [Related]
26. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
Miyata H; Himeno K; Nomoto K
Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
[TBL] [Abstract][Full Text] [Related]
27. Radiation response of C3H fibrosarcoma enhanced in mice stimulated by Corynebacterium parvum.
Suit HD; Sedlacek R; Wagner M; Orsi L
Nature; 1975 Jun; 255(5508):493-4. PubMed ID: 1138200
[No Abstract] [Full Text] [Related]
28. Combined radiotherapy and Corynebacterium parvum treatment of a murine fibrosarcoma.
Collins AL; Song CW
Radiology; 1977 Oct; 125(1):235-41. PubMed ID: 897175
[TBL] [Abstract][Full Text] [Related]
29. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
Ghaffar A; Cullen RT
J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
[TBL] [Abstract][Full Text] [Related]
30. Modification of radiation responses of murine tumors by misonidazole (Ro 07-0582), host immune capability, and Corynebacterium parvum.
Stone HB; Milas L
J Natl Cancer Inst; 1978 Apr; 60(4):887-93. PubMed ID: 633396
[TBL] [Abstract][Full Text] [Related]
31. The correlation of susceptibility of different Propionibacterium strains to macrophage killing and antitumor activity.
Roszkowski W; Ko HL; Roszkowski K; Szmigielski S; Jeljaszewicz J; Pulverer G
Med Microbiol Immunol; 1980; 169(1):1-8. PubMed ID: 7464684
[TBL] [Abstract][Full Text] [Related]
32. Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. I. Use of bacterial adjuvants in induction of immunity demonstrable in Winn tests.
Palladino MA; Thorbecke GJ
Cell Immunol; 1978 Jul; 38(2):336-49. PubMed ID: 354799
[No Abstract] [Full Text] [Related]
33. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
Milas L; Hunter N; Mason K; Withers HR
Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
[No Abstract] [Full Text] [Related]
34. Efficacy of Corynebacterium parvum treatment of mice with sarcoma growing in normal or irradiated tissue.
Suit HD; Sedlacek R; Echteler S
Cancer Res; 1977 Nov; 37(11):4233-4. PubMed ID: 908052
[No Abstract] [Full Text] [Related]
35. Chemotherapy and immunotherapy of diabetic and non-diabetic mice bearing fibrosarcoma.
Pavelić K; Hrsak I
Eur J Cancer (1965); 1980 Oct; 16(10):1297-301. PubMed ID: 7009161
[No Abstract] [Full Text] [Related]
36. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
37. Antitumour effects of Corynebacterium parvum in mice.
Castro JE
Eur J Cancer (1965); 1974 Feb; 10(2):121-7. PubMed ID: 4435007
[No Abstract] [Full Text] [Related]
38. Comparison of the potentiation of specific tumor immunity in mice by Corynebacterium parvum or BCG.
Scott MT; Bomford R
J Natl Cancer Inst; 1976 Sep; 57(3):555-9. PubMed ID: 978769
[TBL] [Abstract][Full Text] [Related]
39. The immunospecificity of altered initial arrest patterns of circulating cancer cells in tumor-bearing mice.
Weiss L; Glaves D
Int J Cancer; 1976 Dec; 18(6):774-7. PubMed ID: 1036490
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of Corynebacterium parvum extracts.
McBride WH; Dawes J; Tuach S
J Natl Cancer Inst; 1976 Feb; 56(2):437-9. PubMed ID: 1255777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
